Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease

Abroad (travel likely)Recruiting

Conditions

NASH · NAFLD

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Medicina Trapianti Fegato and UOC CEMAD, Rome, Lazio, Italy
Contact: Study coordinator (Luca Miele) · luca.miele@policlinicogemelli.it · +390630155701
Contact: Principal Investigator (Luca Miele)

Study leads

Luca Miele
Principal Investigator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease

NASH · NAFLD

Abroad (travel likely)Recruiting

Roma, Italy

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients

Non-alcoholic Fatty Liver Disease (NAFLD) · Alcoholic Liver Disease (ALD) · Liver Fibrosis

Abroad (travel likely)Recruiting

Angers, France · Angers, France

Reversal of Lipid-Induced Insulin Resistance

Insulin Resistance · NAFLD

Abroad (travel likely)Recruiting

New Haven, United States · New Haven, United States

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

NAFLD

Abroad (travel likely)RecruitingPHASE2

Richmond, United States